APA (7th ed.) Citation

YS, C., CH, C., SM, K., CP, L., TH, W., SC, S., . . . PF, L. (2025). Glucagon-like peptide-1 receptor agonists linked to a reduced risk of developing asthma among patients with type 2 diabetes. Therapeutic advances in endocrinology and metabolism, 16, 20420188251400536. https://doi.org/10.1177/20420188251400536

Chicago Style (17th ed.) Citation

YS, Cheng, et al. "Glucagon-like Peptide-1 Receptor Agonists Linked to a Reduced Risk of Developing Asthma Among Patients with Type 2 Diabetes." Therapeutic Advances in Endocrinology and Metabolism 16 (2025): 20420188251400536. https://doi.org/10.1177/20420188251400536.

MLA (9th ed.) Citation

YS, Cheng, et al. "Glucagon-like Peptide-1 Receptor Agonists Linked to a Reduced Risk of Developing Asthma Among Patients with Type 2 Diabetes." Therapeutic Advances in Endocrinology and Metabolism, vol. 16, 2025, p. 20420188251400536, https://doi.org/10.1177/20420188251400536.